[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2557477T3 - Nuevos compuestos peptídicos cíclicos - Google Patents

Nuevos compuestos peptídicos cíclicos Download PDF

Info

Publication number
ES2557477T3
ES2557477T3 ES06822844.4T ES06822844T ES2557477T3 ES 2557477 T3 ES2557477 T3 ES 2557477T3 ES 06822844 T ES06822844 T ES 06822844T ES 2557477 T3 ES2557477 T3 ES 2557477T3
Authority
ES
Spain
Prior art keywords
cyclic peptide
peptide compounds
alkyl
new cyclic
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06822844.4T
Other languages
English (en)
Inventor
Masahiro Neya
Seiji Yoshimura
Kazunori Kamijyo
Takuya Makino
Minoru Yasuda
Toshio Yamanaka
Eisaku Tsujii
Yukiko Yamagishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ES2557477T3 publication Critical patent/ES2557477T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un compuesto péptido cíclico de la siguiente fórmula general (I): **Fórmula** donde X es**Fórmula** en el que R1 es alquilo C1-6; R2 es alquilo C1-6; Y es **Fórmula** en el que R3 es alquilo C1-6 que está opcionalmente sustituido con hidroxi o alcoxi C1-6; R4 es hidrógeno; and R5 es alquilo C1-6; y el resto es un doble enlace; o una sal del mismo.
ES06822844.4T 2005-10-26 2006-10-26 Nuevos compuestos peptídicos cíclicos Active ES2557477T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73001105P 2005-10-26 2005-10-26
US730011P 2005-10-26
US75120405P 2005-12-19 2005-12-19
US751204P 2005-12-19
PCT/JP2006/321924 WO2007049803A1 (en) 2005-10-26 2006-10-26 New cyclic peptide compounds

Publications (1)

Publication Number Publication Date
ES2557477T3 true ES2557477T3 (es) 2016-01-26

Family

ID=37847219

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06822844.4T Active ES2557477T3 (es) 2005-10-26 2006-10-26 Nuevos compuestos peptídicos cíclicos

Country Status (17)

Country Link
US (2) US7872097B2 (es)
EP (1) EP1957518B1 (es)
JP (1) JP5218051B2 (es)
KR (1) KR101273681B1 (es)
CN (1) CN101305019B (es)
AU (1) AU2006306974B2 (es)
BR (1) BRPI0617781A2 (es)
CA (1) CA2623898C (es)
ES (1) ES2557477T3 (es)
IL (1) IL190286A0 (es)
NO (1) NO20082354L (es)
PL (1) PL1957518T3 (es)
PT (1) PT1957518E (es)
RU (1) RU2423377C2 (es)
TW (1) TWI391403B (es)
WO (1) WO2007049803A1 (es)
ZA (1) ZA200803525B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2396170T3 (es) * 2007-05-02 2013-02-19 Astellas Pharma Inc. Nuevos compuestos péptídicos ciclicos
MX2011003259A (es) * 2008-09-24 2011-04-21 Astellas Pharma Inc Compuesto de peptido y metodo para producir el mismo.
NZ594755A (en) * 2009-01-30 2013-12-20 Enanta Pharm Inc Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
CN102459160A (zh) * 2009-05-15 2012-05-16 荷兰癌症研究所基金会 赖氨酸化合物和其在肽和蛋白质的位点选择性和化学选择性修饰中的用途
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
WO2011082289A1 (en) * 2009-12-30 2011-07-07 Scynexis Inc. Cyclosporine analogues
JP2015529206A (ja) * 2012-08-25 2015-10-05 ザ・ジョンズ・ホプキンス・ユニバーシティ Ｇａｐｄｈカスケードインヒビター化合物ならびに使用の方法および精神病を含むストレス誘導障害の処置
JP2015532277A (ja) 2012-09-29 2015-11-09 ノバルティス アーゲー 環状ペプチドおよび医薬としてのその使用
US8906853B2 (en) 2012-11-28 2014-12-09 Enanta Pharmaceuticals, Inc. [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
MX2016002458A (es) * 2013-08-26 2016-08-08 Enanta Pharm Inc Análogos novedosos de ciclosporina para prevenir o tratar la infección por hepatitis c.
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271267A (ja) * 1991-04-23 1993-10-19 Fujisawa Pharmaceut Co Ltd Ｆｒ９０１４５９物質、その製法及び用途
EP1091975B1 (fr) 1998-07-01 2005-12-14 Debiopharm S.A. Nouvelle cyclosporine ayant un profil d'activite ameliore
US20040033946A1 (en) 2000-10-19 2004-02-19 Futoshi Shibasaki Cell damage inhibitor
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
JP2007015926A (ja) 2003-10-06 2007-01-25 Fujisawa Pharmaceut Co Ltd Ｃ型肝炎治療剤
ES2357587T3 (es) 2004-10-01 2011-04-27 Debiopharm S.A. Uso de (d-meala)3-(etval)4-ciclosporina para el tratamiento de infección por hepatitis c.
ATE530561T1 (de) 2004-10-01 2011-11-15 Scynexis Inc 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion
DE602005010607D1 (de) * 2004-11-22 2008-12-04 Astellas Pharma Inc Zyklosporinanalog

Also Published As

Publication number Publication date
US7872097B2 (en) 2011-01-18
WO2007049803A1 (en) 2007-05-03
BRPI0617781A2 (pt) 2011-08-09
EP1957518A1 (en) 2008-08-20
RU2008116674A (ru) 2009-10-27
AU2006306974B2 (en) 2011-09-22
KR20080065297A (ko) 2008-07-11
PT1957518E (pt) 2016-02-26
CA2623898C (en) 2013-12-24
IL190286A0 (en) 2011-08-01
TW200732351A (en) 2007-09-01
ZA200803525B (en) 2009-08-26
RU2423377C2 (ru) 2011-07-10
AU2006306974A1 (en) 2007-05-03
US20100286033A1 (en) 2010-11-11
US20090170755A1 (en) 2009-07-02
TWI391403B (zh) 2013-04-01
EP1957518B1 (en) 2015-12-09
US8252895B2 (en) 2012-08-28
CA2623898A1 (en) 2007-05-03
CN101305019A (zh) 2008-11-12
JP2009513562A (ja) 2009-04-02
JP5218051B2 (ja) 2013-06-26
PL1957518T3 (pl) 2016-07-29
NO20082354L (no) 2008-07-01
KR101273681B1 (ko) 2013-06-25
CN101305019B (zh) 2012-12-12

Similar Documents

Publication Publication Date Title
ES2557477T3 (es) Nuevos compuestos peptídicos cíclicos
ES2421746T3 (es) Nueva sal hidrogenosulfato
CO5611131A2 (es) Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
EA200702670A1 (ru) Препарат тиенопиридинового ингибитора агрегации тромбоцитов
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
AR042851A1 (es) Acidos hidroxamicos inhibidores de histona desacetilasa
RS53746B1 (en) CRYSTAL TRIPEPTIDE EPOXYKETONE PROTEASE INHIBITORS
CO5700747A2 (es) Piperidinas novedosas como moduladores de quimoquina (ccr)
CR11245A (es) Mejoras en compuestos organicos o relacionadas con los mismos
ATE542798T1 (de) Organische verbindungen
UY30387A1 (es) Nuevos compuestos
ES2531056T3 (es) Espirociclos como inhibidores de 11-beta hidroxilesteroide deshidrogenasa tipo 1
ME01992B (me) Jedinjenje diarilhidantoina
ES2436020T3 (es) Derivados de sulfonamida sustituidos
UY29388A1 (es) Derivados del (1,5-difenil-h-pirazol-3-il)oxadiazol, su preparación y su aplicacion en terapéutica.
AR073201A1 (es) Compuestos de amida y su uso.
AR079426A1 (es) Composicion de control de plagas
AR054583A1 (es) Pantoprazol isotopicamente sustituido
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
NO20085317L (no) Imidazoazepinonforbindelser
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
CO6251285A2 (es) Derivado de tetrahidroisoquinolina novedoso
TW200626564A (en) Carboxylic acid derivative containing thiazole ring and medical use thereof
CY1111081T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγκομελατινης